(Q50488787)

14 March 2018

title

Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. (English)

1 reference

14 March 2018

Adaptive radiation therapy

main subject

0 references

0 references

1 reference

Eugene Huang

1

1 reference

14 March 2018

Bin S Teh

2

1 reference

14 March 2018

Douglas R Strother

3

1 reference

14 March 2018

Quillin G Davis

4

1 reference

14 March 2018

J Kam Chiu

5

1 reference

14 March 2018

Hsin H Lu

6

1 reference

14 March 2018

L Steven Carpenter

7

1 reference

14 March 2018

Wei Yuan Mai

8

1 reference

14 March 2018

Murali M Chintagumpala

9

1 reference

14 March 2018

Michael South

10

1 reference

14 March 2018

Walter H Grant

11

1 reference

14 March 2018

E Brian Butler

12

1 reference

14 March 2018

Shiao Y Woo

13

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

14 March 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

14 March 2018

volume

52

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

599-605

1 reference

14 March 2018

Postirradiation sensorineural hearing loss: a common but ignored late radiation complication.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

A prospective longitudinal study on radiation-induced hearing loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Long-term hearing status after radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Hearing loss in children receiving cisplatin chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

cis-platinum ototoxicity in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Radiotherapy enhanced ototoxicity of cisplatin in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Platinum chemotherapy, radiotherapy and the inner ear: implications for "standard" radiation portals.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Sensori‐Neural hearing loss following radiotherapy to the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Effects of cranial radiation on hearing in children with acute lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Pediatric medulloblastoma: radiation treatment technique and patterns of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Medulloblastoma: the Duke University Medical Center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Comparison of posterior fossa and tumor bed boost in medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Ototoxicity of preradiation cisplatin for children with central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902641-4

7 January 2021

10.1016/S0360-3016(01)02641-4

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

11849779

1 reference

14 March 2018